PRESS RELEASE
News
-
-
PRESS RELEASE
Protagonist Announces New Icotrokinra Data in Ulcerative Colitis Showing Potential for a Standout Combination of Therapeutic Benefit and a Favorable Safety Profile in Once-daily Pill
Icotrokinra meets primary clinical endpoints in Phase 2b study for ulcerative colitis treatment, showing promising results at Week 12. Phase 3 trials expected to start in Q4 2025 -
-
-
-
PRESS RELEASE
Troy Minerals Achieves Key Milestone Toward Operational Mining License for Its Tsagaan Zalaa Silica Project, Mongolia
Troy Minerals Inc. subsidiary Grand Samsara completed key regulatory milestone in Mongolia for Tsagaan Zalaa Silica Project, advancing towards mining license. Location strategically positioned for high-purity quartz demand -
-
PRESS RELEASE
Nextech3D.ai Expands Blockchain Ticketing Strategy With Acquisition of EventToken.com, EventDrop.io, and NextechTickets.com, Raises $595,000
Nextech3D.ai raises $595,000 by converting warrants to accelerate blockchain ticketing rollout with strategic domain acquisitions for its Event Token Ecosystem, positioning to lead digital event ticketing through blockchain technology -
-
PRESS RELEASE
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
Telomir Pharmaceuticals unveils new preclinical findings showing Telomir-1 reactivates tumor suppressor genes MASPIN and RASSF1A in aggressive prostate cancer models, offering potential for improved chemotherapy response and metastasis control
